Other
Cervicitis
3
Pipeline Programs↗
0
Active Trials↗
2
Companies Involved↗
Cervicitis is an early-stage landscape with 3 programs across 2 companies. The most active players are Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 2 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 2
No programs
Phase 32
Approved
No programs
Analysis
Trial Status
2
clinical trials
Terminated1 · 50%
Unknown status1 · 50%
Clinical Trials
Trial Activity
Empiric Therapy of Mucopurulent Cervicitis (MPC)
Terminated·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT01072136·87 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)